Related Experiment Video
Updated: Jun 20, 2026
06:17
Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
RANK(L) as a key target for controlling bone loss.
Andreas Leibbrandt1, Josef M Penninger
1Institute of Molecular Biotechnology of the Austrian, Academy of Sciences, Vienna, Austria.
Advances in Experimental Medicine and Biology
|September 18, 2009
Summary
Understanding bone metabolism through key molecules like RANK, RANKL, and OPG offers new treatments for bone diseases. Targeting RANK-RANKL signaling in osteoclasts can revolutionize therapies for osteoporosis and arthritis.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Bone-related diseases like osteoporosis and rheumatoid arthritis impact millions globally.
- Understanding molecular mechanisms of bone metabolism is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of receptor activator of NF-kappaB (RANK), its ligand RANKL, and osteoprotegerin (OPG) in bone metabolism.
- To explore the potential of targeting the RANK-RANKL signaling pathway for treating bone loss conditions.
Main Methods:
- Genetic experiments focusing on RANK, RANKL, and OPG.
- Analysis of downstream signaling pathways involved in osteoclast function.
- Investigating the crosstalk between signaling pathways in bone homeostasis.
Main Results:
- Established the pivotal role of RANK, RANKL, and OPG as central regulators of osteoclast function.
- Demonstrated that RANK-RANKL signaling activates pathways essential for osteoclast development.
- Highlighted the fine-tuning of bone homeostasis through signaling crosstalk.
Conclusions:
- Targeting RANK-RANKL signaling pathways in osteoclasts presents a promising therapeutic strategy.
- Novel drugs targeting this pathway are expected to revolutionize the treatment of bone loss disorders.
- This research advances the understanding of bone metabolism for treating osteoporosis, arthritis, and cancer metastases.
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:25Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:21Skeleton and Calcium Homeostasis
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.